Eric Moessinger

Eric joined NanoDimension in 2008 and was the first employee of NanoDimension’s Silicon Valley office. He is involved in deal sourcing, due diligence and deal structuring and focuses on NanoDimension’s life sciences investments together with Carl Pabo and Colin Walsh. He is a board member of Emulate and a board observer of Twist Bioscience, IonPath and Click Diagnostics. In addition to his investment and board roles at NanoDimension, Eric serves on the Commercialization Advisory Council for the Oregon Nanoscience and Microtechnologies Institute (ONAMI). Previously, Eric was a consultant at Bain & Company in Zurich and San Francisco. While at Bain, Eric worked on strategy cases in healthcare, industrial goods and telecommunications and on the turn-around of an electrical component manufacturer. In addition, Eric spent eight months in Bain’s Private Equity Group. Eric has an MS.c. from the London School of Economics and a BS/BA from the University of Florida.